Edwards Lifesciences Corp (EW)
Edwards Lifesciences Corp (EW) carries a ŷRobot AI score of 58 out of 100. The model's fair value estimate is $88.78, 2.7% above the last close of $86.45. The chart signal reads Bullish.
| Metric | EW |
|---|---|
| AI score | 58 / 100 |
| Chart signal | Bullish |
| Fair value estimate | $88.78 |
| Upside to fair value | 2.7% |
| Previous close | $86.45 |
| P/E | 51.38 |
| Price / sales | 7.54 |
| Market cap | $49.80B |
| EPS | 1.68 |
| Revenue growth | 2.6% |
| 1-year price change | 0.8% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about EW
Is EW overvalued or undervalued right now?
As of Oct 14, 2026, ŷRobot's fair-value model estimates Edwards Lifesciences Corp (EW) at $88.78 against a last close of $86.45, implying 2.7% upside to the model's estimate.
Is EW's chart signal bullish or bearish?
The chart-signal model classifies EW as Bullish as of Oct 14, 2026, with a signal score of 0.16 on a -1 to 1 scale.
What is EW's ŷRobot AI score?
EW scores 58 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 14, 2026.
Is EW stock expensive on P/E and P/S?
EW trades at 51.4 times earnings and 7.5 times sales as of Oct 14, 2026.
What does EW's seasonal forecast show?
ŷRobot's seasonal forecast curve for EW reads -3.3% at 30 days, +1.8% at 90 days, and +0.8% at one year as of Oct 14, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is EW growing?
Edwards Lifesciences Corp's revenue growth is +2.6% and free-cash-flow growth is +7.5% on the latest reported figures.
EW chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.